FDA Inspection 1204369 — Wooshin Lapache D.O.O.

Wooshin Lapache D.O.O. — FEI 3018034328

The FDA completed an inspection of Wooshin Lapache D.O.O. on Aug 29, 2022 in Grosuplje. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 29, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grosuplje (Slovenia)

Additional Details

Mutual Recognition Agreement (MRA)